Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM
Clinical trial NCT00597493 · COMPLETED
Trial details
- NCT number
- NCT00597493
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.